| VRTX | Vertex Pharmaceuticals Inc | $121.26B | +5650429.79% |
| VRNA | Verona Pharma Plc | $77.75B | +3622913.37% |
| REGN | Regeneron Pharmaceuticals Inc | $69.10B | +3220076.28% |
| ARGX | Argen X SE | $57.12B | +2661837.64% |
| ALNY | Alnylam Pharmaceuticals Inc | $36.95B | +1721829.35% |
| RVMD | Revolution Medicines Inc | $36.92B | +1720408.49% |
| ONC | BeiGene Ltd | $36.03B | +1679122.90% |
| MRNA | Moderna Inc | $27.11B | +1263088.09% |
| ROIV | Roivant Sciences Ltd | $25.13B | +1171097.05% |
| RPRX | Royalty Pharma plc - Class A | $24.60B | +1146052.00% |
| INSM | Insmed Inc | $23.78B | +1107868.99% |
| BNTX | BioNTech SE | $23.26B | +1083942.78% |
| INCY | Incyte Corp | $23.01B | +1072257.34% |
| GMAB | Genmab | $18.57B | +865218.87% |
| ASND | Ascendis Pharma A/S | $17.33B | +807411.96% |
| BBIO | BridgeBio Pharma Inc | $16.18B | +753754.13% |
| JAZZ | Jazz Pharmaceuticals plc | $14.81B | +690225.07% |
| EXEL | Exelixis Inc | $14.09B | +656635.12% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.68B | +590730.19% |
| AXSM | Axsome Therapeutics Inc | $12.21B | +569065.15% |
| SMMT | Summit Therapeutics Inc | $11.69B | +544865.18% |
| BMRN | Biomarin Pharmaceutical Inc | $11.39B | +530820.77% |
| TECH | Bio-Techne Corp | $11.19B | +521247.79% |
| ABVX | Abivax | $10.86B | +505886.87% |
| KRYS | Krystal Biotech Inc | $10.31B | +480344.57% |
| CYTK | Cytokinetics Inc | $10.18B | +474510.30% |
| ARWR | Arrowhead Pharmaceuticals Inc | $10.10B | +470362.63% |
| APGE | Apogee Therapeutics Inc | $10.06B | +468505.53% |
| NUVL | Nuvalent Inc - Class A | $9.75B | +454340.23% |
| KYMR | Kymera Therapeutics Inc | $9.38B | +436941.83% |
| CORT | Corcept Therapeutics Inc | $9.35B | +435805.80% |
| IONS | Ionis Pharmaceuticals Inc | $9.08B | +423017.74% |
| HALO | Halozyme Therapeutics Inc | $8.99B | +418665.04% |
| PRAX | Praxis Precision Medicines Inc | $8.87B | +413288.01% |
| CRNX | Crinetics Pharmaceuticals Inc | $8.84B | +411648.54% |
| PTGX | Protagonist Therapeutics Inc | $8.70B | +405327.40% |
| TGTX | TG Therapeutics Inc | $8.64B | +402337.02% |
| PCVX | Vaxcyte Inc | $8.19B | +381479.25% |
| IMVT | Immunovant Inc | $8.13B | +378902.71% |
| IBRX | ImmunityBio Inc | $8.10B | +377169.47% |
| SYRE | Spyre Therapeutics Inc | $8.05B | +374897.13% |
| RYTM | Rhythm Pharmaceuticals Inc | $7.51B | +349759.20% |
| MTSR | Metsera Inc | $7.40B | +344954.92% |
| MIRM | Mirum Pharmaceuticals Inc | $7.37B | +343436.76% |
| MRUS | Merus N.V | $6.83B | +317975.51% |
| COGT | Cogent Biosciences Inc | $6.71B | +312650.35% |
| ACLX | Arcellx Inc | $6.67B | +310530.85% |
| XENE | Xenon Pharmaceuticals Inc | $6.54B | +304775.40% |
| PTCT | PTC Therapeutics Inc | $6.53B | +304402.57% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +302531.66% |
| SRRK | Scholar Rock Holding Corp | $6.44B | +299833.42% |
| CGON | Cg Oncology Inc | $6.42B | +299283.48% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | +291918.69% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +277056.56% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $5.93B | +276413.47% |
| BLTE | Belite Bio Inc | $5.88B | +273913.49% |
| ERAS | Erasca Inc | $5.51B | +256500.00% |
| DNTH | Dianthus Therapeutics Inc | $5.45B | +254025.57% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +244487.44% |
| TVTX | Travere Therapeutics Inc | $5.24B | +244222.18% |
| CRSP | CRISPR Therapeutics AG | $4.95B | +230630.65% |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | +229873.79% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +209798.24% |
| ACAD | Acadia Pharmaceuticals Inc | $4.43B | +206549.33% |
| CELC | Celcuity Inc | $4.42B | +206070.06% |
| EWTX | Edgewise Therapeutics Inc | $4.39B | +204401.83% |
| VKTX | Viking Therapeutics Inc | $4.38B | +204097.97% |
| AKRO | Akero Therapeutics Inc | $4.38B | +204014.31% |
| TNGX | Tango Therapeutics Inc | $4.36B | +203117.83% |
| ORKA | ARCA biopharma Inc | $4.35B | +202470.45% |
| LEGN | Legend Biotech Corp | $4.26B | +198240.40% |
| DYN | Dyne Therapeutics Inc | $3.96B | +184583.37% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | +179192.21% |
| TLX | Telix Pharmaceuticals Ltd | $3.82B | +178135.06% |
| NAMS | NewAmsterdam Pharma Company NV | $3.73B | +173726.56% |
| RLAY | Relay Therapeutics Inc | $3.69B | +171922.04% |
| DNLI | Denali Therapeutics Inc | $3.65B | +170094.96% |
| ALMS | Alumis Inc | $3.60B | +167785.50% |
| GPCR | Structure Therapeutics Inc | $3.53B | +164232.33% |
| RCUS | Arcus Biosciences Inc | $3.52B | +163768.64% |
| ARQT | Arcutis Biotherapeutics Inc | $3.47B | +161772.16% |
| ELVN | Enliven Therapeutics Inc | $3.24B | +150738.60% |
| IDYA | Ideaya Biosciences Inc | $3.23B | +150316.45% |
| BEAM | Beam Therapeutics Inc | $3.17B | +147554.18% |
| RARE | Ultragenyx Pharmaceutical Inc | $3.12B | +145155.89% |
| VERA | Vera Therapeutics Inc - Class A | $3.04B | +141458.77% |
| IRON | Disc Medicine Inc | $2.90B | +135190.34% |
| MBX | MBX Biosciences Inc | $2.89B | +134402.75% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +127657.02% |
| KOD | Kodiak Sciences Inc | $2.64B | +122767.08% |
| IMNM | Immunome Inc | $2.59B | +120774.67% |
| QURE | uniQure N.V. | $2.58B | +120330.79% |
| TARS | Tarsus Pharmaceuticals Inc | $2.47B | +115175.10% |
| NRIX | Nurix Therapeutics Inc | $2.47B | +115154.39% |
| MLYS | Mineralys Therapeutics Inc | $2.43B | +113221.27% |
| VCEL | Vericel Corp | $2.38B | +110956.03% |
| AGIO | Agios Pharmaceuticals Inc | $2.37B | +110152.28% |
| MESO | Mesoblast Ltd | $2.36B | +109721.57% |
| ETNB | 89bio Inc | $2.34B | +109080.63% |
| TRVI | Trevi Therapeutics Inc | $2.33B | +108478.38% |
| SLS | SELLAS Life Sciences Group Inc | $2.32B | +107976.28% |
| PHVS | Pharvaris NV | $2.30B | +106899.33% |
| ZLAB | Zai Lab Ltd | $2.27B | +105649.63% |
| BHVN | Biohaven Ltd | $2.24B | +104191.81% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +103221.88% |
| OCUL | Ocular Therapeutix Inc | $2.18B | +101497.49% |
| PVLA | Palvella Therapeutics Inc | $2.18B | +101266.05% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.11B | +98011.82% |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | +96946.50% |
| IOVA | Iovance Biotherapeutics Inc | $2.08B | +96670.30% |
| ABCL | AbCellera Biologics Inc | $2.05B | +95364.02% |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | +95167.30% |
| HRMY | Harmony Biosciences Holdings Inc | $2.02B | +94011.63% |
| ADMA | Adma Biologics Inc | $2.02B | +93857.69% |
| SION | Sionna Therapeutics Inc | $2.00B | +93120.90% |
| GLUE | Monte Rosa Therapeutics Inc | $1.97B | +91886.65% |
| ATAI | ATAI Life Sciences N.V. | $1.96B | +91208.44% |
| VRDN | Viridian Therapeutics Inc | $1.95B | +90902.47% |
| URGN | UroGen Pharma Ltd | $1.94B | +90237.87% |
| TYRA | Tyra Biosciences Inc | $1.93B | +89633.89% |
| NBTX | Nanobiotix | $1.91B | +88946.26% |
| RAPP | Rapport Therapeutics Inc | $1.91B | +88856.75% |
| GLPG | Galapagos NV | $1.90B | +88358.86% |
| AAPG | Ascentage Pharma Group International | $1.87B | +86982.37% |
| STOK | Stoke Therapeutics Inc | $1.86B | +86650.59% |
| SRPT | Sarepta Therapeutics Inc | $1.86B | +86534.05% |
| BCAX | Bicara Therapeutics Inc | $1.84B | +85776.66% |
| ZBIO | Zenas Biopharma Inc | $1.83B | +85396.42% |
| PGEN | Precigen Inc | $1.82B | +84815.47% |
| ZYME | Zymeworks BC Inc | $1.80B | +83906.02% |
| TSHA | Taysha Gene Therapies Inc | $1.78B | +82765.80% |
| IMCR | Immunocore Holdings plc | $1.76B | +82048.51% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.76B | +81746.99% |
| FTRE | Fortrea Holdings Inc | $1.69B | +78853.38% |
| NKTR | Nektar Therapeutics | $1.69B | +78629.11% |
| MPLT | MapLight Therapeutics Inc | $1.69B | +78544.10% |
| GHRS | GH Research PLC | $1.67B | +77719.61% |
| ANAB | AnaptysBio Inc | $1.62B | +75414.89% |
| INVA | Innoviva Inc | $1.62B | +75189.29% |
| NTLA | Intellia Therapeutics Inc | $1.57B | +73091.30% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +72800.69% |
| VIR | Vir Biotechnology Inc | $1.55B | +72104.48% |
| SEPN | Septerna Inc | $1.53B | +71212.02% |
| AVBP | ArriVent BioPharma Inc | $1.49B | +69470.21% |
| ABSI | Absci Corp | $1.49B | +69469.21% |
| MAZE | Maze Therapeutics Inc | $1.46B | +68019.05% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.42B | +66193.90% |
| NVAX | Novavax Inc | $1.39B | +64491.15% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +64366.75% |
| INBX | Inhibrx Biosciences Inc | $1.33B | +61993.14% |
| ARDX | Ardelyx Inc | $1.31B | +60897.22% |
| IMTX | Immatics N.V | $1.28B | +59318.82% |
| MNKD | Mannkind Corp | $1.26B | +58775.62% |
| ANNX | Annexon Inc | $1.26B | +58722.95% |
| CRVS | Corvus Pharmaceuticals Inc | $1.25B | +58365.46% |
| TRML | Tourmaline Bio Inc | $1.24B | +57484.53% |
| SVRA | Savara Inc | $1.19B | +55381.61% |
| CAPR | Capricor Therapeutics Inc | $1.17B | +54583.74% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.16B | +53761.16% |
| ORIC | ORIC Pharmaceuticals Inc | $1.15B | +53622.04% |
| WVE | Wave Life Sciences Ltd | $1.14B | +52870.69% |
| XNCR | Xencor Inc | $1.11B | +51601.48% |
| DRTS | Alpha Tau Medical Ltd | $1.10B | +51001.40% |
| CGEM | Cullinan Oncology Inc | $1.10B | +50958.37% |
| JBIO | Jade Biosciences Inc | $1.08B | +50167.33% |
| CVAC | CureVac N.V. | $1.05B | +48797.42% |
| OLMA | Olema Pharmaceuticals Inc | $1.03B | +48003.84% |
| MGTX | MeiraGTx Holdings plc | $1.02B | +47569.88% |
| KURA | Kura Oncology Inc | $1.01B | +46764.70% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +46440.03% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +46027.60% |
| VOR | Vor Biopharma Inc | $979.68M | +45552.67% |
| JANX | Janux Therapeutics Inc | $975.67M | +45366.17% |
| ANRO | Alto Neuroscience Inc | $973.06M | +45244.57% |
| SANA | Sana Biotechnology Inc | $957.85M | +44535.63% |
| GERN | Geron Corp | $950.51M | +44193.69% |
| SLDB | Solid Biosciences Inc | $946.56M | +44009.37% |
| PHAR | Pharming Group N.V. | $939.88M | +43698.28% |
| LXRX | Lexicon Pharmaceuticals Inc | $936.56M | +43543.43% |
| DBVT | DBV Technologies | $930.17M | +43245.52% |
| LBRX | LB Pharmaceuticals Inc | $922.18M | +42873.51% |
| ABUS | Arbutus Biopharma Corp | $898.08M | +41750.43% |
| PHAT | Phathom Pharmaceuticals Inc | $877.84M | +40807.08% |
| TBPH | Theravance Biopharma Inc | $872.15M | +40541.96% |
| DSGN | Design Therapeutics Inc | $844.21M | +39239.92% |
| REPL | Replimune Group Inc | $800.70M | +37212.45% |
| ACRS | Aclaris Therapeutics Inc | $782.06M | +36343.65% |
| OCS | Oculis Holding AG | $772.84M | +35914.06% |
| ZVRA | Zevra Therapeutics Inc | $766.13M | +35601.43% |
| CMRX | Chimerix Inc | $766.03M | +35596.84% |
| RIGL | Rigel Pharmaceuticals | $758.21M | +35232.25% |
| SPRY | ARS Pharmaceuticals Inc | $749.72M | +34836.61% |
| OMER | Omeros Corporation | $746.63M | +34692.61% |
| MNPR | Monopar Therapeutics Inc | $728.12M | +33830.29% |
| DRUG | Bright Minds Biosciences Inc | $728.06M | +33827.48% |
| ATXS | Astria Therapeutics Inc | $709.95M | +32983.57% |
| CADL | Candel Therapeutics Inc | $706.21M | +32809.05% |
| XOMA | XOMA Royalty Corp | $699.64M | +32503.12% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $673.55M | +31287.19% |
| CLYM | Eliem Therapeutics Inc | $662.55M | +30774.68% |
| CRMD | CorMedix Inc | $660.09M | +30659.98% |
| IVA | Inventiva | $655.21M | +30432.87% |
| CTMX | CytomX Therapeutics Inc | $652.36M | +30300.06% |
| RLMD | Relmada Therapeutics Inc | $651.37M | +30253.63% |
| MDXG | Mimedx Group Inc | $635.94M | +29534.53% |
| RGNX | Regenxbio Inc | $633.34M | +29413.54% |
| PRME | Prime Medicine Inc | $630.35M | +29274.09% |
| NGNE | Neoleukin Therapeutics Inc | $616.04M | +28607.47% |
| TECX | AvroBio Inc | $611.99M | +28418.57% |
| FDMT | 4D Molecular Therapeutics Inc | $610.53M | +28350.71% |
| GYRE | Gyre Therapeutics Inc | $599.17M | +27821.27% |
| IMMX | Immix Biopharma Inc | $558.22M | +25912.81% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $555.56M | +25789.15% |
| CTNM | Contineum Therapeutics Inc - Class A | $546.27M | +25356.07% |
| ARVN | Arvinas Inc | $534.06M | +24787.09% |
| NVCT | Nuvectis Pharma Inc | $519.64M | +24114.89% |
| STTK | Shattuck Labs Inc | $511.69M | +23744.59% |
| ZURA | Zura Bio Ltd - Class A | $511.41M | +23731.46% |
| VSTM | Verastem Inc | $503.34M | +23355.56% |
| SLN | Silence Therapeutics Plc | $493.60M | +22901.74% |
| OCGN | Ocugen Inc | $483.80M | +22444.80% |
| KYTX | Kyverna Therapeutics Inc | $470.94M | +21845.84% |
| ALLO | Allogene Therapeutics Inc | $465.15M | +21575.95% |
| SVA | Sinovac Biotech Ltd | $464.94M | +21566.05% |
| CABA | Cabaletta Bio Inc | $463.15M | +21482.70% |
| RZLT | Rezolute Inc | $456.43M | +21169.34% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +20935.66% |
| EVMN | Evommune Inc | $447.71M | +20763.12% |
| PRTA | Prothena Corporation plc | $447.44M | +20750.66% |
| BNTC | Benitec Biopharma Inc | $447.29M | +20743.78% |
| VALN | Valneva SE | $440.98M | +20449.51% |
| CBIO | N/A | $432.05M | +20033.54% |
| STRO | Sutro Biopharma Inc | $430.74M | +19972.25% |
| AURA | Aura Biosciences Inc | $430.49M | +19960.71% |
| PBYI | Puma Biotechnology Inc | $427.89M | +19839.78% |
| ASMB | Assembly Biosciences Inc | $424.80M | +19695.71% |
| OVID | Ovid Therapeutics Inc | $416.49M | +19308.51% |
| ABEO | Abeona Therapeutics Inc | $414.56M | +19218.22% |
| DMAC | DiaMedica Therapeutics Inc | $411.67M | +19083.68% |
| CYBN | Cybin Inc | $408.43M | +18932.85% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +18715.28% |
| AUTL | Autolus Therapeutics plc | $401.88M | +18627.37% |
| RCKT | Rocket Pharmaceuticals Inc | $398.30M | +18460.76% |
| LRMR | Larimar Therapeutics Inc | $395.79M | +18343.92% |
| UPB | Upstream Bio Inc | $395.63M | +18336.43% |
| CCCC | C4 Therapeutics Inc | $395.34M | +18322.68% |
| IPSC | Century Therapeutics Inc | $390.82M | +18112.23% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +18082.69% |
| AVIR | Atea Pharmaceuticals Inc | $388.93M | +18024.14% |
| CMPX | Compass Therapeutics Inc | $385.39M | +17859.02% |
| ENTA | Enanta Pharmaceuticals Inc | $384.48M | +17816.55% |
| RVNC | Revance Therapeutics Inc | $380.38M | +17625.49% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +17467.36% |
| ALT | Altimmune Inc | $373.67M | +17313.17% |
| TENX | Tenax Therapeutics Inc | $372.39M | +17253.12% |
| PRLD | Prelude Therapeutics Inc | $368.04M | +17050.55% |
| XFOR | X4 Pharmaceuticals Inc | $367.85M | +17041.59% |
| FENC | Fennec Pharmaceuticals Inc | $366.13M | +16961.80% |
| VNDA | Vanda Pharmaceuticals Inc | $351.79M | +16293.35% |
| LXEO | Lexeo Therapeutics Inc | $351.17M | +16264.50% |
| EDIT | Editas Medicine Inc | $349.39M | +16181.28% |
| FATE | Fate Therapeutics Inc | $347.65M | +16100.64% |
| FBRX | Forte Biosciences Inc | $340.15M | +15751.02% |
| ZNTL | Zentalis Pharmaceuticals Inc | $340.13M | +15749.81% |
| PALI | Palisade Bio Inc | $339.87M | +15737.69% |
| IMAB | I-Mab | $339.64M | +15726.97% |
| EPRX | Eupraxia Pharmaceuticals Inc | $338.64M | +15680.72% |
| IMRX | Immuneering Corp Class A | $333.64M | +15447.53% |
| LYEL | Lyell Immunopharma Inc | $332.66M | +15402.02% |
| FHTX | Foghorn Therapeutics Inc | $319.97M | +14810.64% |
| INDP | Indaptus Therapeutics Inc | $319.34M | +14781.33% |
| ANL | Adlai Nortye Ltd | $317.46M | +14693.36% |
| GALT | Galectin Therapeutics Inc | $313.48M | +14508.05% |
| LCTX | Lineage Cell Therapeutics Inc | $305.39M | +14131.13% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +14115.74% |
| ELDN | Eledon Pharmaceuticals Inc | $304.92M | +14109.39% |
| SCPH | scPharmaceuticals Inc | $304.59M | +14093.85% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +14013.30% |
| OABI | OmniAb Inc | $301.15M | +13933.54% |
| BCYC | Bicycle Therapeutics Plc | $294.16M | +13607.97% |
| NMRA | Neumora Therapeutics Inc | $293.19M | +13562.66% |
| GLSI | Greenwich LifeSciences Inc | $286.57M | +13254.27% |
| TTRX | Turn Therapeutics Inc | $285.37M | +13198.16% |
| TRDA | Entrada Therapeutics Inc | $276.01M | +12762.22% |
| NAGE | Niagen Bioscience Inc | $275.72M | +12748.30% |
| MGNX | Macrogenics Inc | $274.58M | +12695.35% |
| SABS | SAB Biotherapeutics Inc | $274.20M | +12677.45% |
| ALXO | Alx Oncology Holdings Inc | $273.12M | +12627.23% |
| IKT | Inhibikase Therapeutics Inc | $271.99M | +12574.55% |
| SRZN | Surrozen Inc | $250.37M | +11567.06% |
| IRD | Ocuphire Pharma Inc | $248.48M | +11479.15% |
| RNAC | Cartesian Therapeutics Inc | $247.77M | +11445.95% |
| THRD | Third Harmonic Bio Inc | $241.86M | +11170.84% |
| FULC | Fulcrum Therapeutics Inc | $237.12M | +10949.97% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +10758.31% |
| ACIU | AC Immune SA | $232.87M | +10751.65% |
| AVXL | Anavex Life Sciences Corporation | $231.68M | +10696.21% |
| IVVD | Invivyd Inc | $231.05M | +10666.92% |
| QTTB | Q32 Bio Inc | $229.68M | +10603.16% |
| SLRN | Acelyrin Inc | $228.54M | +10550.12% |
| DTIL | Precision Biosciences Inc | $227.35M | +10494.46% |
| TARA | Protara Therapeutics Inc | $226.83M | +10470.18% |
| CGEN | Compugen Ltd | $223.15M | +10298.54% |
| CHRS | Coherus Biosciences Inc | $222.07M | +10248.57% |
| NAUT | Nautilus Biotechnology Inc | $221.10M | +10203.34% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +10087.07% |
| KROS | Keros Therapeutics Inc | $217.65M | +10042.59% |
| ADAG | Adagene Inc | $217.38M | +10029.93% |
| SLGL | Sol-Gel Technologies Ltd | $215.10M | +9923.83% |
| KPTI | Karyopharm Therapeutics Inc | $214.84M | +9911.70% |
| OBIO | Orchestra BioMed Holdings Inc | $214.00M | +9872.45% |
| RNA | Atrium Therapeutics Inc | $210.40M | +9704.57% |
| IMUX | Immunic Inc | $205.68M | +9484.85% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +9304.12% |
| CDXS | Codexis Inc | $200.88M | +9260.77% |
| NKTX | Nkarta Inc | $197.53M | +9104.68% |
| AGEN | Agenus Inc | $192.99M | +8893.48% |
| VYGR | Voyager Therapeutics Inc | $192.99M | +8893.47% |
| NERV | Minerva Neurosciences Inc | $189.40M | +8725.88% |
| KRRO | Korro Bio Inc | $187.93M | +8657.32% |
| PRQR | ProQR Therapeutics N.V | $186.49M | +8590.45% |
| PLX | Protalix BioTherapeutics Inc | $186.05M | +8569.79% |
| TNYA | Tenaya Therapeutics Inc | $182.97M | +8426.53% |
| MDWD | MediWound Ltd | $182.55M | +8406.99% |
| IFRX | InflaRx N.V. | $182.18M | +8389.46% |
| WHWK | Whitehawk Therapeutics Inc | $181.71M | +8367.50% |
| ARCT | Arcturus Therapeutics Holdings Inc | $181.62M | +8363.59% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +8325.78% |
| ACOG | Alpha Cognition Inc | $180.73M | +8321.75% |
| MENS | Jyong Biotech Ltd | $174.10M | +8013.22% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +7987.06% |
| PEPG | PepGen Inc | $168.86M | +7768.75% |
| ANTX | AN2 Therapeutics Inc | $168.05M | +7731.22% |
| CRBU | Caribou Biosciences Inc | $167.73M | +7715.98% |
| THTX | Theratechnologies Inc | $167.34M | +7697.85% |
| ALEC | Alector Inc | $166.54M | +7660.63% |
| ORMP | Oramed Pharmaceuticals Inc | $166.16M | +7643.02% |
| EQ | Equillium Inc | $165.65M | +7619.42% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $164.92M | +7585.46% |
| IPHA | Innate Pharma | $164.54M | +7567.60% |
| OTLK | Outlook Therapeutics Inc | $163.20M | +7505.00% |
| YDES | YD Bio Ltd | $160.69M | +7388.20% |
| ABOS | Acumen Pharmaceuticals Inc | $160.35M | +7372.05% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $159.83M | +7347.92% |
| LENZ | LENZ Therapeutics Inc | $156.46M | +7190.93% |
| PYXS | Pyxis Oncology Inc | $152.68M | +7014.85% |
| CNTB | Connect Biopharma Holdings Ltd | $152.39M | +7001.32% |
| HUMA | Humacyte Inc | $151.33M | +6951.86% |
| MIST | Milestone Pharmaceuticals Inc | $149.60M | +6871.28% |
| NBP | NovaBridge Biosciences. | $149.30M | +6857.25% |
| NRXP | NRX Pharmaceuticals Inc | $149.28M | +6856.51% |
| AKTX | Akari Therapeutics Plc | $148.12M | +6802.57% |
| MOLN | Molecular Partners AG | $146.63M | +6733.16% |
| ARMP | Armata Pharmaceuticals Inc | $146.49M | +6726.24% |
| AARD | Aardvark Therapeutics Inc | $145.52M | +6680.98% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +6673.58% |
| HURA | TuHURA Biosciences Inc | $144.96M | +6655.06% |
| GUTS | Fractyl Health Inc | $144.37M | +6627.64% |
| PROK | ProKidney Corp - Class A | $137.85M | +6323.79% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +6313.35% |
| CBUS | Cibus Global Ltd. Class A | $135.62M | +6219.90% |
| THAR | Tharimmune Inc | $135.41M | +6210.01% |
| SEER | Seer Inc - Class A | $132.16M | +6058.74% |
| GNLX | Genelux Corp | $130.49M | +5980.60% |
| VXRT | Vaxart Inc | $127.95M | +5862.42% |
| ENGN | enGene Holdings Inc | $127.28M | +5831.22% |
| UNCY | Unicycive Therapeutics Inc | $126.69M | +5803.90% |
| PMN | ProMIS Neurosciences Inc | $125.59M | +5752.59% |
| FBIO | Fortress Biotech Inc | $123.12M | +5637.49% |
| RANI | Rani Therapeutics Holdings Inc Class A | $121.86M | +5578.52% |
| VANI | Vivani Medical Inc | $119.35M | +5461.86% |
| ANIX | Anixa Biosciences Inc | $118.73M | +5432.78% |
| ALDX | Aldeyra Therapeutics Inc | $115.82M | +5297.02% |
| SAVA | Cassava Sciences Inc. | $114.97M | +5257.71% |
| RPTX | Repare Therapeutics Inc | $113.91M | +5208.29% |
| COYA | Coya Therapeutics Inc | $113.53M | +5190.60% |
| KLRS | Kalaris Therapeutics Inc | $110.82M | +5064.32% |
| ONCY | Oncolytics Biotech Inc | $104.98M | +4792.04% |
| HLVX | HilleVax Inc | $104.74M | +4780.81% |
| BDTX | Black Diamond Therapeutics Inc | $103.72M | +4733.15% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +4671.97% |
| SPRO | Spero Therapeutics Inc | $98.42M | +4486.14% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +4454.68% |
| VRCA | Verrica Pharmaceuticals Inc | $97.23M | +4430.99% |
| ICCC | Immucell Corp | $97.07M | +4423.54% |
| PYPD | Polypid Ltd | $94.84M | +4319.66% |
| BMEA | Biomea Fusion Inc | $93.27M | +4246.19% |
| CUE | Cue Biopharma Inc | $92.75M | +4221.91% |
| ENLV | Enlivex Ltd | $92.47M | +4208.93% |
| PTHS | Channel Therapeutics Corporation | $91.66M | +4171.41% |
| MAIA | MAIA Biotechnology Inc | $89.19M | +4056.10% |
| NTHI | NeOnc Technologies Holdings Inc | $87.88M | +3995.25% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +3953.73% |
| CRDF | Cardiff Oncology Inc | $85.46M | +3882.53% |
| RLYB | Rallybio Corp | $85.33M | +3876.43% |
| CGTX | Cognition Therapeutics Inc | $84.81M | +3851.93% |
| LPTX | Leap Therapeutics Inc | $84.76M | +3849.74% |
| ATHE | Alterity Therapeutics Ltd | $84.66M | +3845.19% |
| ACET | Adicet Bio Inc | $83.31M | +3782.13% |
| HRTX | Heron Therapeutics Inc | $83.25M | +3779.65% |
| ENTX | Entera Bio Ltd | $82.99M | +3767.20% |
| INO | Inovio Pharmaceuticals Inc | $81.63M | +3704.16% |
| CSBR | Champions Oncology Inc | $80.27M | +3640.37% |
| NRXS | Neuraxis Inc | $79.92M | +3624.32% |
| FBIOP | Fortress Biotech Inc | $77.72M | +3521.74% |
| ATHA | Athira Pharma Inc | $77.21M | +3498.19% |
| PMVP | PMV Pharmaceuticals Inc | $74.66M | +3379.35% |
| GLTO | Galecto Inc | $74.66M | +3378.93% |
| ACRV | Acrivon Therapeutics Inc | $74.39M | +3366.58% |
| ATRA | Atara Biotherapeutics Inc | $72.78M | +3291.42% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +3251.74% |
| GANX | Gain Therapeutics Inc | $71.38M | +3226.33% |
| XBIT | XBiotech Inc | $69.82M | +3153.45% |
| PLRX | Pliant Therapeutics Inc | $69.34M | +3131.43% |
| HYFT | MindWalk Holdings Corp | $69.31M | +3129.75% |
| MNOV | Medicinova Inc | $68.91M | +3111.18% |
| SPRB | Spruce Biosciences Inc | $67.96M | +3066.70% |
| IMA | Ikena Oncology Inc | $67.49M | +3045.11% |
| ELTX | Elicio Therapeutics Inc | $65.05M | +2931.47% |
| IMMP | Immutep Ltd | $64.23M | +2893.12% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +2861.57% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +2846.04% |
| EDSA | Edesa Biotech Inc | $61.04M | +2744.68% |
| OSTX | OS Therapies Inc | $60.88M | +2737.05% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +2658.69% |
| IBIO | iBio Inc | $58.38M | +2620.43% |
| CNTX | Context Therapeutics Inc | $57.91M | +2598.66% |
| OKYO | OKYO Pharma Ltd - New | $56.13M | +2515.74% |
| BOLD | Boundless Bio Inc | $55.35M | +2479.08% |
| INMB | INmune Bio Inc | $55.03M | +2464.46% |
| CING | Cingulate Inc | $54.66M | +2447.11% |
| KZR | Kezar Life Sciences Inc | $53.76M | +2405.17% |
| INKT | MiNK Therapeutics Inc | $53.21M | +2379.48% |
| XLO | Xilio Therapeutics Inc | $52.74M | +2357.52% |
| MREO | Mereo Biopharma Group Plc | $52.58M | +2350.33% |
| ATYR | Atyr Pharma Inc | $52.39M | +2341.31% |
| MCRB | Seres Therapeutics Inc | $52.28M | +2336.15% |
| BYSI | BeyondSpring Inc | $52.22M | +2333.54% |
| EXOZ | Invizyne Technologies Inc | $51.89M | +2318.13% |
| RNTX | Rein Therapeutics Inc | $51.79M | +2313.61% |
| TIL | Instil Bio Inc | $51.68M | +2308.21% |
| ANVS | Annovis Bio Inc | $51.65M | +2307.00% |
| GOSS | Gossamer Bio Inc | $51.14M | +2283.13% |
| IBO | Impact BioMedical Inc | $50.13M | +2235.87% |
| MGX | Metagenomi Inc | $48.56M | +2163.11% |
| DWTX | Virios Therapeutics Inc | $48.10M | +2141.37% |
| LVTX | LAVA Therapeutics NV | $45.77M | +2032.93% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +2030.85% |
| DYAI | Dyadic International Inc DE | $44.46M | +1971.60% |
| PDSB | PDS Biotechnology Corporation | $41.64M | +1840.34% |
| APLM | Apollomics Inc - Class A | $41.33M | +1826.05% |
| ACTU | Actuate Therapeutics Inc | $40.78M | +1800.53% |
| FGEN | FibroGen Inc | $39.31M | +1731.66% |
| GRCE | Acasti Pharma Inc | $38.94M | +1714.52% |
| VERU | Veru Inc | $38.84M | +1710.02% |
| RNXT | RenovoRx Inc | $38.73M | +1704.68% |
| NNVC | NanoViricides Inc | $37.23M | +1635.02% |
| NTRB | Nutriband Inc | $37.08M | +1627.72% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +1582.48% |
| GBIO | Generation Bio Company | $35.97M | +1576.13% |
| GNTA | Genenta Science SpA | $35.85M | +1570.66% |
| ALGS | Aligos Therapeutics Inc | $35.71M | +1563.88% |
| MURA | Mural Oncology plc | $35.34M | +1546.95% |
| LTRN | Lantern Pharma Inc | $34.89M | +1525.85% |
| LITS | Lite Strategy Inc | $34.77M | +1520.41% |
| HYPD | Eyenovia Inc | $34.51M | +1508.35% |
| LSTA | Lisata Therapeutics Inc | $34.15M | +1491.49% |
| ABVC | ABVC BioPharma Inc | $32.98M | +1436.98% |
| ESLA | Estrella Immunopharma Inc | $32.50M | +1414.72% |
| SNTI | Senti Biosciences Inc | $32.39M | +1409.39% |
| DARE | Dare Bioscience Inc | $30.14M | +1304.43% |
| SER | AgeX Therapeutics Inc | $29.05M | +1253.87% |
| SGMO | Sangamo Therapeutics Inc | $28.83M | +1243.55% |
| BCTX | BriaCell Therapeutics Corp - New | $28.57M | +1231.21% |
| ATNM | Actinium Pharmaceuticals Inc | $28.56M | +1230.92% |
| CRVO | CervoMed Inc | $28.42M | +1224.57% |
| PSTV | Plus Therapeutics Inc | $28.00M | +1204.66% |
| TVRD | Cara Therapeutics Inc | $27.49M | +1180.90% |
| BRNS | Barinthus Biotherapeutics Plc. | $26.44M | +1131.98% |
| IGC | IGC Pharma Inc | $26.36M | +1128.31% |
| EVAX | Evaxion Biotech A/S | $25.44M | +1085.39% |
| VYNE | VYNE Therapeutics Inc | $25.25M | +1076.87% |
| GRDX | Entero Therapeutics Inc | $24.74M | +1052.81% |
| NXTC | Nextcure Inc | $23.92M | +1014.58% |
| MRKR | Marker Therapeutics Inc | $23.55M | +997.29% |
| NRSN | NeuroSense Therapeutics Ltd | $23.41M | +990.68% |
| CELU | Celularity Inc - Class A | $22.49M | +948.19% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +923.14% |
| OPT | Opthea Ltd | $21.53M | +903.27% |
| SKYE | Skye Bioscience Inc | $21.29M | +892.13% |
| PLRZ | Polyrizon Ltd | $21.02M | +879.53% |
| ATOS | Atossa Therapeutics Inc | $21.01M | +879.14% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +849.53% |
| TVGN | Tevogen Bio Holdings Inc | $19.93M | +828.57% |
| SNSE | Sensei Biotherapeutics Inc | $19.48M | +807.53% |
| JSPR | Jasper Therapeutics Inc | $19.37M | +802.82% |
| KALA | Kala Bio Inc | $19.15M | +792.27% |
| NEUP | Neuphoria Therapeutics Inc | $18.93M | +782.05% |
| NCEL | NLS Pharmaceutics Ltd | $18.85M | +778.60% |
| ALLR | Allarity Therapeutics Inc | $18.67M | +769.85% |
| ICU | SeaStar Medical Holding Corp | $18.45M | +759.81% |
| PLUR | Pluri Inc | $18.25M | +750.63% |
| LPCN | Lipocine Inc | $17.64M | +722.08% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.55M | +718.00% |
| HOWL | Werewolf Therapeutics Inc | $16.50M | +668.83% |
| HIND | ReShape Lifesciences Inc | $15.93M | +642.43% |
| PTN | Palatin Technologies Inc | $15.81M | +636.69% |
| PASG | Passage Bio Inc | $15.75M | +633.96% |
| LGVN | Longeveron Inc - Class A | $15.75M | +633.79% |
| CYCN | Cyclerion Therapeutics Inc | $15.74M | +633.25% |
| TPST | Tempest Therapeutics Inc | $15.35M | +615.22% |
| APLT | Applied Therapeutics Inc | $14.86M | +592.61% |
| HOTH | Hoth Therapeutics Inc | $14.64M | +582.38% |
| LEXX | Lexaria Bioscience Corp | $14.58M | +579.31% |
| IOBT | IO Biotech Inc | $14.50M | +575.62% |
| HOOK | Hookipa Pharma Inc | $14.43M | +572.27% |
| INAB | IN8bio Inc | $14.18M | +560.78% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $14.00M | +552.36% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $13.82M | +544.05% |
| BIVI | BioVie Inc - Class A | $13.35M | +522.06% |
| BLRX | Bioline Rx Ltd | $13.35M | +521.90% |
| LNAI | Lunai Bioworks Inc | $13.33M | +520.96% |
| COCP | Cocrystal Pharma Inc | $13.24M | +516.77% |
| QNCX | Quince Therapeutics Inc | $13.03M | +507.37% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +506.76% |
| GTBP | GT Biopharma Inc | $12.33M | +474.47% |
| MBRX | Moleculin Biotech Inc | $12.33M | +474.43% |
| CALC | CalciMedica Inc | $12.31M | +473.45% |
| INTS | Intensity Therapeutics Inc | $12.30M | +473.00% |
| AIM | AIM ImmunoTech Inc. | $12.01M | +459.66% |
| KTTA | Pasithea Therapeutics Corp | $11.92M | +455.53% |
| QNRX | Quoin Pharmaceuticals Ltd | $11.92M | +455.39% |
| CTXR | Citius Pharmaceuticals Inc | $11.88M | +453.80% |
| GDTC | CytoMed Therapeutics Ltd | $11.32M | +427.54% |
| TOVX | Theriva Biologics Inc | $11.15M | +419.46% |
| CMMB | Chemomab Therapeutics Ltd | $10.93M | +409.44% |
| BCLI | Brainstorm Cell Therapeutics Inc | $10.73M | +400.18% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +385.87% |
| PHIO | Phio Pharmaceuticals Corp | $10.34M | +381.87% |
| XCUR | Exicure Inc | $10.33M | +381.18% |
| CVM | Cel-Sci Corp | $10.15M | +372.78% |
| MLEC | Moolec Science SA | $10.06M | +368.67% |
| KPRX | Kiora Pharmaceuticals Inc | $9.90M | +361.52% |
| BCDA | BioCardia Inc | $9.59M | +346.70% |
| MTVA | MetaVia Inc | $9.55M | +345.22% |
| VTGN | VistaGen Therapeutics Inc | $9.48M | +341.61% |
| CRIS | Curis Inc | $9.45M | +340.60% |
| TRAW | Traws Pharma Inc | $9.16M | +326.93% |
| ASBP | Aspire Biopharma Holdings Inc | $9.03M | +320.77% |
| EPIX | Essa Pharma Inc | $8.93M | +316.18% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +315.55% |
| IMNN | Imunon Inc | $8.71M | +305.72% |
| BRTX | BioRestorative Therapies Inc | $8.66M | +303.67% |
| APRE | Aprea Therapeutics Inc | $8.48M | +295.12% |
| ADXN | Addex Therapeutics Ltd | $8.21M | +282.36% |
| SYBX | Synlogic Inc | $8.20M | +282.27% |
| IMRN | Immuron Ltd | $8.15M | +279.90% |
| BOLT | Bolt Biotherapeutics Inc | $8.09M | +276.98% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +275.65% |
| RNAZ | TransCode Therapeutics Inc | $7.97M | +271.54% |
| ERNA | Ernexa Therapeutics Inc | $7.85M | +265.68% |
| PMCB | PharmaCyte Biotech Inc | $7.57M | +252.90% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $7.49M | +248.80% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +241.85% |
| AEON | AEON Biopharma Inc - Class A | $7.31M | +240.65% |
| BCAB | BioAtla Inc | $7.07M | +229.46% |
| CANF | Can-Fite Biopharma Ltd | $6.87M | +220.37% |
| KAPA | Kairos Pharma Ltd | $6.75M | +214.49% |
| XBIO | Xenetic Biosciences Inc | $6.65M | +209.98% |
| JUNS | Jupiter Neurosciences Inc | $6.48M | +201.79% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +198.24% |
| GOVX | Geovax Labs Inc | $6.29M | +192.90% |
| CURX | Curanex Pharmaceuticals Inc | $6.11M | +184.58% |
| PPBT | Purple Biotech Ltd | $6.05M | +181.91% |
| HCWB | HCW Biologics Inc | $6.02M | +180.66% |
| APM | Aptorum Group Limited Class A Ordinary Shares | $6.01M | +180.21% |
| ACXP | Acurx Pharmaceuticals Inc | $5.93M | +176.38% |
| CVKD | Cadrenal Therapeutics Inc | $5.89M | +174.52% |
| PULM | Pulmatrix Inc | $5.73M | +167.21% |
| EVGN | Evogene Ltd | $5.64M | +162.98% |
| APVO | Aptevo Therapeutics Inc | $5.50M | +156.35% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.30M | +146.86% |
| SILO | SILO Pharma Inc | $5.29M | +146.48% |
| DRMA | Dermata Therapeutics Inc | $5.23M | +143.66% |
| LIMN | Liminatus Pharma Inc | $5.14M | +139.45% |
| TCRT | Alaunos Therapeutics Inc | $5.07M | +136.07% |
| BGMS | Bio Green Med Solution Inc | $5.00M | +132.87% |
| NCNA | NuCana plc | $4.99M | +132.57% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | +128.79% |
| ALZN | Alzamend Neuro Inc | $4.68M | +118.08% |
| GNPX | Genprex Inc | $4.44M | +106.91% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | +98.76% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | +98.70% |
| REVB | Revelation Biosciences Inc | $4.26M | +98.52% |
| MBIO | Mustang Bio Inc | $4.25M | +98.20% |
| ADIL | Adial Pharmaceuticals Inc | $4.24M | +97.62% |
| ENVB | Enveric Biosciences Inc | $4.15M | +93.51% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | +92.85% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $4.09M | +90.45% |
| SNGX | Soligenix Inc | $3.91M | +82.34% |
| PBM | Psyence Biomedical Ltd | $3.76M | +75.36% |
| CELZ | Creative Medical Technology Holdings Inc | $3.70M | +72.26% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.38M | +57.49% |
| XRTX | XORTX Therapeutics Inc | $3.34M | +55.73% |
| FBLG | FibroBiologics Inc | $3.18M | +48.18% |
| SLXN | Silexion Therapeutics Corp | $3.11M | +44.95% |
| SPRC | SciSparc Ltd | $3.05M | +41.92% |
| BDRX | Biodexa Pharmaceuticals Plc | $2.98M | +38.96% |
| AFMD | Affimed N.V. | $2.98M | +38.64% |
| ENSC | Ensysce Biosciences Inc | $2.88M | +34.03% |
| ARTL | Artelo Biosciences Inc | $2.75M | +27.97% |
| GRI | GRI Bio Inc | $2.57M | +19.65% |
| ONCO | Onconetix Inc | $2.54M | +18.33% |
| PPCB | Propanc Biopharma Inc | $2.50M | +16.58% |
| VIVS | VivoSim Labs Inc | $2.47M | +15.04% |
| OGEN | Oragenics Inc | $2.45M | +14.19% |
| NBY | Stablecoin Development Corp | $2.40M | +12.05% |
| NTBL | Notable Labs Inc Ord | $2.39M | +11.59% |
| BBLG | Bone Biologics Corp | $2.23M | +3.74% |
| AZTR | Azitra Inc | $2.22M | +3.60% |
| MTNB | Matinas Biopharma Holdings Inc | $2.18M | +1.71% |
| CMND | Clearmind Medicine Inc | $2.12M | -1.44% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -2.70% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -7.07% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -27.36% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -29.20% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -33.51% |
| JAGX | Jaguar Health Inc | $1.34M | -37.39% |
| ZVSA | ZyVersa Therapeutics Inc | $1.03M | -52.01% |
| LYRA | Lyra Therapeutics Inc | $927198.36 | -56.79% |
| SCNI | Scinai Immunotherapeutics Ltd | $912143.15 | -57.49% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -74.32% |
| PTIX | Protagenic Therapeutics Inc | $503648.74 | -76.53% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -79.18% |
| ELAB | PMGC Holdings Inc | $221376.00 | -89.68% |
| CDT | CDT Equity Inc | $110551.31 | -94.85% |
| ADTX | Aditxt Inc | $98471.97 | -95.41% |